retatrutide clinical trial results obesity just delivered the first top-line Phase 3 for a triple agonist in — and the findings from TRIUMPH-4 are striking👇 Advancements in Clinical Research and

It started as a volunteer project in 2014

Summary: GLP-1 receptor agonists are prescription medications that may support weight management during perimenopause by suppressing appetite and delaying gastric emptying, but they are not specifically indicated for hormonal changes and require strict NHS eligibility criteria

: - (TRIUMPHOutcomes, III)

doi: 10.1056/NEJMc2109509

Mather KJ, Mari A, Heise T, DeVries JH, Hua M, Urva S et al (2024) Effects of tirzepatide vs semaglutide on -cell function, insulin sensitivity, and glucose control during a meal test

Among these benefits, one stands out for long-term health: lowering LDL cholesterol , the so-called bad cholesterol that plays a central role in heart disease